US Map / Arkansas
State AR

Clinical Trials in Arkansas

Arkansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arkansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 102 actively recruiting studies with Arkansas sites out of 102 registered in total. The busiest research areas in Arkansas are Atopic Dermatitis, B Acute Lymphoblastic Leukemia, Schizophrenia. Leading sponsors running trials in the state include National Cancer Institute (NCI), Pfizer, University of Arkansas. By stage, Arkansas trials break down as Phase 1 (9), Phase 2 (30), Phase 3 (39), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
102
Recruiting Now
102
← Back to US Map
Top Conditions in Arkansas
Atopic Dermatitis (4)B Acute Lymphoblastic Leukemia (3)Schizophrenia (3)Malignant Solid Neoplasm (2)Atrial Fibrillation (2)Non-muscle Invasive Bladder Cancer With Carcinoma in Situ (2)Clear Cell Renal Cell Carcinoma (2)Ulcerative Colitis (2)Heart Failure (2)Heart Diseases (2)Cardiovascular Diseases (2)Non-Small Cell Lung Cancer (2)

Frequently Asked Questions — Clinical Trials in Arkansas

How many clinical trials are currently recruiting in Arkansas?
ClinicalMetric currently tracks 102 actively recruiting clinical trials with at least one location in Arkansas. The total number of registered studies—including active but not currently enrolling trials—is 102. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arkansas?
Arkansas hosts clinical trials across a broad range of medical conditions, including Atopic Dermatitis, B Acute Lymphoblastic Leukemia, Schizophrenia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arkansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arkansas?
To join a clinical trial in Arkansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arkansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Arkansas

NCT06989112 Phase 3
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegos...
Condition
Endometrial Cancer
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
View Trial →
NCT05952934 Phase 2
Recruiting
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrenc...
Condition
Squamous Cell Carcinoma of Head and Neck
Enrollment
100 pts
Location
United States
Sponsor
University of Arkansas
View Trial →
Page 5 of 5 — 102 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology